Astellas Pharma ADR (ALPMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 06-2019 | 12-2018 | 09-2018 | 06-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,360,740 | 2,948,534 | 2,761,803 | 2,849,617 | 2,951,979 |
| Marketable Securities | 35,799 | 194,705 | 256,509 | 218,058 | 547,786 |
| Receivables | 3,471,441 | 3,281,243 | 3,082,140 | 3,204,525 | 3,192,021 |
| Inventories | 1,369,905 | 1,291,986 | 1,341,774 | 1,339,456 | 1,301,723 |
| Other current assets | 225,298 | 206,828 | 167,400 | 159,897 | 240,771 |
| TOTAL | $7,463,183 | $7,923,296 | $7,609,626 | $7,771,553 | $8,234,280 |
| Non-Current Assets | |||||
| PPE Net | 2,292,272 | 1,555,702 | 1,649,781 | 1,653,875 | 1,640,555 |
| Investments And Advances | 785,803 | 688,486 | 800,127 | 781,190 | 656,873 |
| Intangibles | 5,858,880 | 5,869,300 | 5,737,878 | 5,779,789 | 5,523,028 |
| Other Non-Current Assets | 1,135,855 | 1,125,317 | 1,184,930 | 1,185,863 | 1,156,359 |
| TOTAL | $10,072,810 | $9,238,805 | $9,372,716 | $9,400,717 | $8,976,815 |
| Total Assets | $17,535,980 | $17,162,090 | $16,982,330 | $17,172,270 | $17,211,100 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,274,318 | 1,705,480 | 1,312,488 | 1,270,732 | 1,227,301 |
| Other current liabilities | 2,331,411 | 2,224,600 | 2,367,819 | 2,392,212 | 2,078,996 |
| TOTAL | $4,223,874 | $4,418,832 | $4,028,220 | $4,035,552 | $3,521,089 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,893,610 | 1,195,840 | 1,197,513 | 783,500 | 1,177,470 |
| TOTAL | $1,939,765 | $1,242,609 | $1,409,949 | $1,398,244 | $1,524,926 |
| Total Liabilities | $6,163,639 | $5,661,430 | $5,438,160 | $5,433,796 | $5,046,006 |
| Shareholders' Equity | |||||
| Common Shares | 937,309 | 916,709 | 927,009 | 947,609 | 916,709 |
| Retained earnings | 7,775,149 | 8,571,278 | 8,227,593 | 7,955,663 | 8,501,556 |
| Other shareholders' equity | 1,090,390 | 1,367,637 | 1,743,488 | 1,509,209 | 1,846,594 |
| TOTAL | $11,372,340 | $11,500,660 | $11,544,170 | $11,738,470 | $12,165,090 |
| Total Liabilities And Equity | $17,535,979 | $17,162,090 | $16,982,330 | $17,172,266 | $17,211,096 |